Severity and Determinants of Anemia in TB/HIV Coinfected Adults at Mekelle, Ethiopia: Hospital Based Retrospective Study

Overview

Journal J Trop Med

Publisher Wiley

Specialty Tropical Medicine

Date 2023 May 26

PMID 37234694

Authors

Kebede Embaye Gezae

Kiflom Hagos

Assefa Ayalew Gebreslassie

Affiliations

Soon will be listed here.

Abstract

Background: Anemia has up to 87% prevalence in high tuberculosis (TB) and human immunodeficiency virus (HIV) burden settings of the sub-Saharan Africa (SSA) including Ethiopia. It increases lost to follow-up (LTFU) rate, reduces quality of life, and shortens the survival of TB/HIV coinfected patients. However, there is limited information on severity level and determinants of anemia in TB/HIV coinfected adults in the study setting in particular. Therefore, this study is aimed to assess severity level and determinants of TB/HIV-associated anemia.

Methods: A hospital based retrospective study was conducted among 305 TB/HIV coinfected adults who enrolled for antiretroviral therapy (ART) from January, 2009 to December, 2016 in two public hospital of Mekelle, Ethiopia, by reviewing ART register. A multiple logit model was fitted to identify the baseline determinants of anemia using 95% confidence level or 5% level of significance for adjusted odds ratio (AOR).

Results: In the current study, the cumulative baseline prevalence of anemia was 59.0% (95% CI: 53.3%-64.6%). Considering severity level, the prevalence was 6.2%, 28.2%, and 24.6% for severe, moderate, and mild anemia, respectively. Being female (AOR = 0.380; 95% CI: 0.226-0.640), body mass index (AOR = 0.913; 95% CI: 0.836-0.998) reduces the odds of developing anemia whereas baseline ambulatory functional status (AOR = 2.139; 95% CI: 1.189-3.846), bedridden functional status (AOR = 2.208; 95% CI: 1.002-4.863), HIV clinical stage III (AOR = 2.565; 95% CI: 1.030-6.384), and HIV clinical stage IV (AOR = 2.590; 95% CI: 1.006-6.669) increased the odds of developing anemia for TB/HIV coinfected adults.

Conclusions: In the current study, significant TB/HIV-associated severe anemia was assessed which accounted for nearly one-ninth of all anemia cases while nearly half were moderate anemia. Therefore, curious attention has to be given for the management of TB/HIV-associated severe anemia in particular and anemia in general to reducing anemia associated bad outcomes most importantly death.

Citing Articles

Sex differences in the risk profiles for anemia in people living with HIV, A cross sectional study.

Kamvuma K, Hamooya B, Chiyenu K, Ademola Y, Mudenda S, Machiko A PLoS One. 2025; 20(3):e0319611.

PMID: 40063574 PMC: 11892841. DOI: 10.1371/journal.pone.0319611.

References

Johannessen A, Naman E, Gundersen S, Bruun J . Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infect Dis. 2011; 11:190. PMC: 3145581. DOI: 10.1186/1471-2334-11-190. View

Mugusi F, Mehta S, Villamor E, Urassa W, Saathoff E, Bosch R . Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health. 2009; 9:409. PMC: 2779816. DOI: 10.1186/1471-2458-9-409. View

Kerkhoff A, Wood R, Vogt M, Lawn S . Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays. J Acquir Immune Defic Syndr. 2013; 66(1):33-40. PMC: 3981888. DOI: 10.1097/QAI.0000000000000091. View

OBrien M, Kupka R, Msamanga G, Saathoff E, Hunter D, Fawzi W . Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr. 2005; 40(2):219-25. DOI: 10.1097/01.qai.0000166374.16222.a2. View

Assefa M, Abegaz W, Shewamare A, Medhin G, Belay M . Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia. BMC Hematol. 2015; 15:6. PMC: 4455710. DOI: 10.1186/s12878-015-0024-6. View

Minchella P, Donkor S, Owolabi O, Sutherland J, McDermid J . Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions. Clin Infect Dis. 2014; 60(5):764-72. DOI: 10.1093/cid/ciu945. View

Owiredu W, Quaye L, Amidu N, Addai-Mensah O . Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci. 2011; 11(1):2-15. PMC: 3092327. View

Smith Jr R . The clinical and economic burden of anemia. Am J Manag Care. 2010; 16 Suppl Issues:S59-66. View

Ferede G, Wondimeneh Y . Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia. BMC Hematol. 2013; 13(1):8. PMC: 4176740. DOI: 10.1186/2052-1839-13-8. View

10.

Gedefaw L, Yemane T, Sahlemariam Z, Yilma D . Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study. PLoS One. 2013; 8(8):e72202. PMC: 3745448. DOI: 10.1371/journal.pone.0072202. View

11.

Mocroft A, Kirk O, Barton S, Dietrich M, Proenca R, Colebunders R . Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS. 1999; 13(8):943-50. DOI: 10.1097/00002030-199905280-00010. View

12.

Omoregie R, Omokaro E, Palmer O, Ogefere H, Egbeobauwaye A, Adeghe J . Prevalence of anaemia among HIV-infected patients in Benin City, Nigeria. Tanzan J Health Res. 2009; 11(1):1-4. DOI: 10.4314/thrb.v11i1.43242. View

13.

Gezae K, Abebe H, Gebretsadik L . Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach. BMC Infect Dis. 2019; 19(1):107. PMC: 6360725. DOI: 10.1186/s12879-019-3756-2. View

14.

Melese H, Wassie M, Woldie H, Tadesse A, Mesfin N . Anemia among adult HIV patients in Ethiopia: a hospital-based cross-sectional study. HIV AIDS (Auckl). 2017; 9:25-30. PMC: 5317259. DOI: 10.2147/HIV.S121021. View

15.

Masaisa F, Gahutu J, Mukiibi J, Delanghe J, Philippe J . Anemia in human immunodeficiency virus-infected and uninfected women in Rwanda. Am J Trop Med Hyg. 2011; 84(3):456-60. PMC: 3042824. DOI: 10.4269/ajtmh.2011.10-0519. View

16.

Wallis R, Pai M, Menzies D, Doherty T, Walzl G, Perkins M . Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010; 375(9729):1920-37. DOI: 10.1016/S0140-6736(10)60359-5. View

17.

Semba R, Shah N, Klein R, Mayer K, Schuman P, Vlahov D . Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis. 2001; 34(2):260-6. DOI: 10.1086/338151. View

18.

Kerkhoff A, Wood R, Cobelens F, Gupta-Wright A, Bekker L, Lawn S . Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa. BMC Infect Dis. 2014; 14:3860. PMC: 4300078. DOI: 10.1186/s12879-014-0702-1. View

19.

Isanaka S, Mugusi F, Urassa W, Willett W, Bosch R, Villamor E . Iron deficiency and anemia predict mortality in patients with tuberculosis. J Nutr. 2011; 142(2):350-7. PMC: 3260062. DOI: 10.3945/jn.111.144287. View

20.

Re M, Zauli G, Furlini G, Giovannini M, La Placa M . HIV-1 infection and hematologic picture. Microbiologica. 1991; 14(2):165-76. View